HTFL Stock Summary and Trading Ideas (Heartflow | NASDAQ:HTFL)

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

Heartflow trades on the NASDAQ stock market under the symbol HTFL.

As of August 18, 2026, HTFL stock price climbed to $45.23 with 4,087,855 million shares trading.

HTFL has a beta of 2.06, meaning it tends to be more sensitive to market movements. HTFL has a correlation of 0.08 to the broad based SPY ETF.

HTFL has a market cap of $3.93 billion. This is considered a Mid Cap stock.

Last quarter Heartflow reported $53 million in Revenue and -$.07 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $.08.

The top ETF exchange traded funds that HTFL belongs to (by Net Assets): IWM, VTI, VB, IWO, VBR.

HTFL has outperformed the market in the last year with a price return of +45.1% while the SPY ETF gained +20.4%. HTFL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +59.7% and +69.0%, respectively, while the SPY returned +4.1% and +1.3%, respectively.

HTFL support price is $40.52 and resistance is $43.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HTFL shares will trade within this expected range on the day.